EuroPCR 2023: Late-Breaking Science Video Collection
Published: 18 May 2023
-
Views:
2136 -
Likes:
7
-
Views:
2136 -
Likes:
7
-
Up Next
-
1m 51s
-
1m 45sPart 4 | Session 3 Dr Sorajja: Why He Chose Cardiovascular Medicine
-
5m 41sPart 1 | Session 1 EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions Sandeep Arunothayaraj
-
6m 12sPart 1 | Session 2 BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction Antonio Mangieri
-
3m 15sPart 1 | Session 3 DRAGONFLY-DMR: Safety and Effectiveness of Dragonfly TMVR System for Mitral Regurgitation D Scott Lim
-
3m 30sPart 1 | Session 4 TRILUMINATE Pivotal: TEER for Tricuspid Regurgitation Paul Sorajja
-
6m 7sPart 1 | Session 5 EBC MAIN Three-Year Follow Up David Hildick-Smith
-
4m 59sPart 1 | Session 6 TVT Registry Analysis: TAVR in Patients with Cardiogenic Shock Abhijeet Dhoble
-
2m 35sPart 1 | Session 7 FAME III Three-Year Follow-Up Frederik Zimmermann
-
29m 21sPart 2 | Session 1 View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview Joost Daemen, Nicolas M Van Mieghem
-
30m 41sPart 2 | Session 2 View from the Thoraxcenter: What's Hot at EuroPCR 23? Joost Daemen, Nicolas M Van Mieghem
-
4m 28sPart 3 3 Trials That Will Change Your Practice With Dr Mirvat Alasnag Mirvat Alasnag
Overview
Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.
Hear commentary on the practice-changing trials of EuroPCR 2023 from selected faculty in our Highlights Reviews.
Watch our Behind the Heart Series to hear more from the personal perspectives of the investigators behind the top trials of EuroPCR 2023.
More from this programme
Part 1
Expert Interviews
Short, concise overviews of the key data revealed at EuroPCR 2023, focussing on the results and impact on future research.
Part 2
View from the Thoraxcenter
In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at EuroPCR 2023.
Part 3
Highlights Reviews
Commentary on the top late-breaking trials of EuroPCR 2023, as chosen by selected faculty.
Part 4
Behind the Heart
Watch our Behind the Heart series to learn more the personal perspectives from the investigators behind top trials in cardiovascular science.
About the episode
In this short interview, investigator Dr Scott Lim describes what he loves about his career, and his advice to young researchers.
Comments